ARTA asks FDA to keep their communications open for Ivermectin applications

31 March 2021 – Anti-Red Tape Authority (ARTA) Director General Jeremiah Belgica, in a meeting earlier, called on the Food and Drug Administration (FDA) to “keep their communications open for the registration of pharmaceutical companies who would want to apply for a Drug Emergency Use or a Compassionate Special Permit for Ivermectin”. During the meeting,.. read more

ARTA to FDA: Expedite application process for Ivermectin

29 March 2021 – The Anti-Red Tape Authority (ARTA) is urging the Food and Drug Administration (FDA) to expedite its processing of applications for the use of Ivermectin, an anti-parasitic drug undergoing trials for the possible treatment of COVID-19 symptoms. This, after the FDA announced earlier today that doctors and hospitals may now apply for.. read more

Gov’t agencies boast faster service in ARTA report to the President

23 March 2021  –  Reforms to ease the doing of business in the country are starting to pay off with several government agencies telling the Anti-Red Tape Authority (ARTA) about the significant reduction in the processing time of their transactions. The said improvements were specifically observed in some of the services of the Local Government.. read more